Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Repisalud
Publicación Artículo científico (JournalArticle)

miRNome analysis reveals mir-155-5p as a protective factor to dengue infection in a resistant Thai cohort

  • Casadémont, Isabelle
  • Ayala-Suarez, Ruben
  • Modhiran, Naphak
  • Tawfik, Ahmed
  • Prot, Matthieu
  • Paul, Richard
  • Simon-Lorière, Etienne
  • Díez-Fuertes, Francisco
  • Ubol, Sukathida
  • Alcamí, José
  • Sakuntabhai, Anavaj
Dengue virus (DENV) is a global health threat, with approximately 390 million infections annually, ranging from mild dengue fever to severe dengue hemorrhagic fever and shock syndrome. MicroRNA (miRNA) are crucial post-transcriptional regulators which may regulate host resistance to DENV infection. This study aimed to identify miRNAs involved in natural resistance to DENV infection. Individuals from a dengue-endemic area were classified as susceptible (SD) or resistant (RD) according to their anti-DENV antibody status. RD individuals were seronegative despite high local DENV infection prevalence. Monocytes susceptibility to DENV infection was assessed in vitro. The miRNome profiles of the monocytes from 7 individuals per group were assessed upon mock or DENV-2 infection. The antiviral effect of differentially expressed miRNAs was analyzed using miRNA mimics in HeLa cells followed by infection with DENV-1, DENV-2, DENV-3, and DENV-4 serotypes. We performed RNA-seq on miRNA mimic-transfected cells to identify miRNA-targeted genes interacting with DENV proteins. Monocytes from RD individuals exhibit lower DENV-2 production in vitro. The miRNAs miR-155, miR-132-3p, miR-576-5p were overexpressed in monocytes from RD group upon DENV-2 infection. The transfection of miR-155-5p mimic reduced DENV infection and viral production in HeLa cells, regulating 18 genes interacting with DENV proteins and downregulating target genes involved in interferon response, TP53 regulation, apoptosis, and vesicle trafficking (e.g. HSD17B12, ANXA2). Therefore, we show that monocytes from RD individuals show a distinct miRNA expression profile and reduced viral production. In vitro miR-155-5p upregulation induces an antiviral state, revealing potential therapeutic targets to treat dengue.
Repisalud
Publicación Artículo científico (JournalArticle)

Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paraganglioma

  • Calsina, Bruna
  • Castro-Vega, Luis Jaime
  • Torres-Pérez, Rafael
  • Inglada Perez, Lucia
  • Currás-Freixes, Maria
  • Roldán-Romero, Juan María
  • Mancikova, Veronika
  • Letón, Rocío
  • Remacha, Laura
  • Santos, María
  • Burnichon, Nelly
  • Lussey-Lepoutre, Charlotte
  • Rapizzi, Elena
  • Graña, Osvaldo
  • Álvarez-Escolá, Cristina
  • de Cubas, Aguirre A
  • Lanillos, Javier
  • Cordero-Barreal, Alfonso
  • Martínez-Montes, Ángel M
  • Bellucci, Alexandre
  • Amar, Laurence
  • Fernandes-Rosa, Fabio Luiz
  • Calatayud, María
  • Aller, Javier
  • Lamas, Cristina
  • Sastre-Marcos, Júlia
  • Canu, Letizia
  • Korpershoek, Esther
  • Timmers, Henri J
  • Lenders, Jacques Wm
  • Beuschlein, Felix
  • Fassnacht-Capeller, Martin
  • Eisenhofer, Graeme
  • Mannelli, Massimo
  • Al-Shahrour, Fatima
  • Favier, Judith
  • Rodriguez Antona, Cristina
  • Cascon Soriano, Alberto
  • Montero-Conde, Cristina
  • Gimenez-Roqueplo, Anne-Paule
  • Robledo Mercedes, Mercedes
Rationale: Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors that present variable outcomes. To date, no effective therapies or reliable prognostic markers are available for patients who develop metastatic PPGL (mPPGL). Our aim was to discover robust prognostic markers validated through in vitro models, and define specific therapeutic options according to tumor genomic features. Methods: We analyzed three PPGL miRNome datasets (n=443), validated candidate markers and assessed them in serum samples (n=36) to find a metastatic miRNA signature. An integrative study of miRNome, transcriptome and proteome was performed to find miRNA targets, which were further characterized in vitro. Results: A signature of six miRNAs (miR-21-3p, miR-183-5p, miR-182-5p, miR-96-5p, miR-551b-3p, and miR-202-5p) was associated with metastatic risk and time to progression. A higher expression of five of these miRNAs was also detected in PPGL patients' liquid biopsies compared with controls. The combined expression of miR-21-3p/miR-183-5p showed the best power to predict metastasis (AUC=0.804, P=4.67·10-18), and was found associated in vitro with pro-metastatic features, such as neuroendocrine-mesenchymal transition phenotype, and increased cell migration rate. A pan-cancer multi-omic integrative study correlated miR-21-3p levels with TSC2 expression, mTOR pathway activation, and a predictive signature for mTOR inhibitor-sensitivity in PPGLs and other cancers. Likewise, we demonstrated in vitro a TSC2 repression and an enhanced rapamycin sensitivity upon miR-21-3p expression. Conclusions: Our findings support the assessment of miR-21-3p/miR-183-5p, in tumors and liquid biopsies, as biomarkers for risk stratification to improve the PPGL patients' management. We propose miR-21-3p to select mPPGL patients who may benefit from mTOR inhibitors.
Repisalud
Publicación Artículo científico (JournalArticle)

Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma.

  • Calsina, Bruna
  • Piñeiro-Yáñez, Elena
  • Martínez-Montes, Ángel M
  • Caleiras, Eduardo
  • Fernández-Sanromán, Ángel
  • Monteagudo, María
  • Torres-Pérez, Rafael
  • Fustero-Torre, Coral
  • Pulgarín-Alfaro, Marta
  • Gil, Eduardo
  • Letón, Rocío
  • Jiménez, Scherezade
  • García-Martín, Santiago
  • Martin, Maria Carmen
  • Roldán-Romero, Juan María
  • Lanillos, Javier
  • Mellid, Sara
  • Santos, María
  • Díaz-Talavera, Alberto
  • Rubio, Ángeles
  • González, Patricia
  • Hernando, Barbara
  • Bechmann, Nicole
  • Dona, Margo
  • Calatayud, María
  • Guadalix, Sonsoles
  • Álvarez-Escolá, Cristina
  • Regojo, Rita M
  • Aller, Javier
  • Del Olmo-Garcia, Maria Isabel
  • López-Fernández, Adrià
  • Fliedner, Stephanie M J
  • Rapizzi, Elena
  • Fassnacht, Martin
  • Beuschlein, Felix
  • Quinkler, Marcus
  • Toledo, Rodrigo A
  • Mannelli, Massimo
  • Timmers, Henri J
  • Eisenhofer, Graeme
  • Rodriguez Perales, Sandra
  • Domínguez, Orlando
  • Macintyre, Geoffrey
  • Currás-Freixes, Maria
  • Rodríguez-Antona, Cristina
  • Cascón, Alberto
  • Leandro-García, Luis J
  • Roncador, Giovanna
  • García-García, Juan Fernando
  • Pacak, Karel
  • Al-Shahrour, Fatima
  • Robledo Batanero, Mercedes
The mechanisms triggering metastasis in pheochromocytoma/paraganglioma are unknown, hindering therapeutic options for patients with metastatic tumors (mPPGL). Herein we show by genomic profiling of a large cohort of mPPGLs that high mutational load, microsatellite instability and somatic copy-number alteration burden are associated with ATRX/TERT alterations and are suitable prognostic markers. Transcriptomic analysis defines the signaling networks involved in the acquisition of metastatic competence and establishes a gene signature related to mPPGLs, highlighting CDK1 as an additional mPPGL marker. Immunogenomics accompanied by immunohistochemistry identifies a heterogeneous ecosystem at the tumor microenvironment level, linked to the genomic subtype and tumor behavior. Specifically, we define a general immunosuppressive microenvironment in mPPGLs, the exception being PD-L1 expressing MAML3-related tumors. Our study reveals canonical markers for risk of metastasis, and suggests the usefulness of including immune parameters in clinical management for PPGL prognostication and identification of patients who might benefit from immunotherapy.